Why the study?
Does scoparone inhibit U46619-induced platelet activation in human platelets?
Does scoparone inhibit U46619-induced platelet activation in human platelets?
Scoparone exhibits strong antiplatelet and antithrombotic effects in vitro by upregulating cAMP and cGMP, suggesting potential as a therapeutic agent for platelet-derived vascular diseases.
Answers are grounded in this paper and cite their sources.
Scoparone's antiplatelet activity is preliminary; leaves open any role in cardiovascular thrombosis prevention.
Platelet activation is essential for hemostatic process on blood vessel damage. However, excessive platelet activation can cause some cardiovascular diseases including atherosclerosis, thrombosis, and myocardial infarction. Scoparone is commonly encountered in the roots of genus Artemisia or Scopolia, and has been studied for its potential pharmacological properties including immunosuppression and vasorelaxation, but antiplatelet effects of scoparone have not been reported yet. We investigated the effect of scoparone on human platelet activation prompted by an analogue of thromboxane A 2 , U46619. As the results, scoparone dose-dependently increased cyclic adenosine monophosphate (cAMP) levels as well as cyclic guanosine monophosphate (cGMP) levels, both being aggregation-inhibiting molecules. In addition, scoparone strongly phosphorylated inositol 1, 4, 5triphosphate receptor (IP 3 R) and vasodilator-stimulated phosphoprotein (VASP), substrates of cAMP dependent kinase and cGMP dependent kinase. Phosphorylation of IP 3 R by scoparone resulted in inhibition of Ca 2+ mobilization in calcium channels in a dense tubular system, and phosphorylation of VASP by scoparone led to an inability of fibrinogen being able to bind to IIb/3. Finally, scoparone inhibited thrombin-induced fibrin clotting, thereby reducing thrombus formation. Therefore, we suggest that scoparone has a strong antiplatelet effect and is highly probable to prevent platelet-derived vascular disease.
No takes yet. Share an insight, caveat, or question.
Dong‐Ha Lee (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: